EPHA3 and breast cancer: In this respect, our analysis revealed that the expression levels of EphA3 are higher in ER-positive than ER-negative BC patients (Fig. 7A) as well as in luminal A and luminal B subtypes respect to the other molecular subgroups (Fig. 7B).